16
22
22
Biosimilar Red Tape Elimination Act
10/18/2025, 8:05 AM
Summary of Bill HR 5526
H.R. 5526, introduced in the 119th Congress on September 19, 2025, aims to enhance the standards for determining the interchangeability of a biological product with its reference product.
Read the Full Bill
Current Status of Bill HR 5526
Bill HR 5526 is currently in the status of Bill Introduced since September 19, 2025. Bill HR 5526 was introduced during Congress 119 and was introduced to the House on September 19, 2025. Bill HR 5526's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 19, 2025
Bipartisan Support of Bill HR 5526
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
3Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5526
Primary Policy Focus
Alternate Title(s) of Bill HR 5526
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Comments
Sponsors and Cosponsors of HR 5526
Latest Bills
Protecting Indian Water Rights Settlements Act of 2026
Bill S 4890August 20, 2026
Lindsey O. Graham Sanctioning Russia and Iran Act of 2026
Bill HR 5334August 20, 2026
Railroad Retirement Board Stability Act
Bill S 4965August 20, 2026
D.C. Taxing Authority Review Act
Bill HR 9720August 20, 2026
Fiscal Sponsorship Transparency Act of 2026
Bill HR 9721August 20, 2026
Fair Treatment of Religious Organizations Act of 2026
Bill HR 9722August 20, 2026
READ Act
Bill S 4689August 20, 2026
NIH IMPROVE Act
Bill HR 6238August 19, 2026
Continuing Appropriations and Extensions Act, 2027
Bill HR 6500August 18, 2026
Permitting Transparency and Accountability Act
Bill S 1735August 18, 2026